Edward Morrow Atkinson III, EVP, Chief Technical Ops. Off: Vertex Pharmaceuticals VRTX Sell · Filed 25/11/19

Trade details

Type: Insider sale
Amount: $1,086,450
Shares · price: 2,500 sh · $434.58 a share
Held after: 16,852 sh
Stock: Vertex Pharmaceuticals VRTX
Person: Edward Morrow Atkinson IIIEVP, Chief Technical Ops. Off
Trade date: 25/11/17
Filed: 25/11/19
Days to filing: 2 days

Sold 12.9% of holdings

Share of holding sold: 12.9%

Vertex Pharmaceuticals trades, last 26 weeks

What else happened in Vertex Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/10/18~25/12/17

Edward Morrow Atkinson III's recent trades

Edward Morrow Atkinson IIIEVP, Chief Technical Ops. Off
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$324.9K
668 sh
$324.9K
Filed 02/26
Traded 02/25
Edward Morrow Atkinson IIIEVP, Chief Technical Ops. Off
Planned sale10b5-1 planVertex Pharmaceuticals
Planned sale10b5-1 plan
Vertex Pharmaceuticals
VRTX
$324.9K
668 sh
$324.9K
Filed 02/25
Traded 02/25
Edward Morrow Atkinson IIIEVP, Chief Technical Ops. Off
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$994.1K
2,031 sh
$994.1K
Filed 02/19
Traded 02/17
Edward Morrow Atkinson IIIEVP, Chief Technical Ops. Off
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$387K
817 sh
$387K
Filed 02/19
Traded 02/18
Edward Morrow Atkinson IIIEVP, Chief Technical Ops. Off
Planned sale10b5-1 planVertex Pharmaceuticals
Planned sale10b5-1 plan
Vertex Pharmaceuticals
VRTX
$387K
817 sh
$387K
Filed 02/18
Traded 02/18